Abstract
For low dose CT lung cancer screening to be effective in curbing disease mortality, efforts are needed to overcome barriers to awareness and facilitate uptake of the current evidence-based screening guidelines. A sequential mixed-methods approach was employed to design a screening campaign utilizing messages developed from community focus groups, followed by implementation of the outreach campaign intervention in two high-risk Kentucky regions. This study reports on rates of awareness and screening in intervention regions, as compared to a control region.
Introduction
Lung cancer remains the leading cause of cancer death in the United States, 1 accounting for about 1 in 4 cancer deaths. 2 Early detection of the disease is notoriously poor, with only 16% of lung cancers diagnosed at a localized stage. The 5-year survival rate is 55% with early detection; however, this rate is cut in half (27%) if detected after regional spread. 2 The potential for change in these statistics will be of special interest in the coming years, given the national coverage decision on Feb. 5, 2015 , by the Centers for Medicare and Medicaid Services (CMS)
for low dose computed tomography (LDCT) lung cancer screening for eligible Medicare beneficiaries. 3 The CMS decision followed evidence from the National Lung Screening trial (NLST) that LDCT reduced lung cancer mortality by 20% compared to standard chest x-ray among adults with at least a 30 pack-year smoking history who were current smokers or had quit within 15 years. 4 Review of the few existing studies on cost analytics, calculated as savings from a shift toward earlier stages at diagnosis relative to increased Medicare expenditures for screenings, also describe favorable results. 5 Along with interventions to curb high rates of smoking, few states stand to benefit more from LDCT screening efforts than Kentucky. Compared to national averages for age-adjusted lung cancer incidence and mortality (63.7 and 47.2 per 100,000, respectively), Kentucky's rates of 97.5 and 70.9 per 100,000, respectively, are the highest in the nation. 6 The impact of the recommendation itself, however, is likely to be minimal unless efforts are made to overcome implementation delays and barriers to awareness and uptake of evidence-based screening guidelines. 7 Early studies on implementation of LDCT screening show that patients are not aware of the recommendation 8 and have limited knowledge of what a screening might entail; 9 primary care providers also have shown limited understanding of the guidelines or the evidence for LDCT effectiveness. 10, 11 One of the CMS requirements when ordering a chest LDCT for lung cancer screening is documentation that a shared decision-making process was conducted and recorded in the medical record. 3 This process is important, given that a primary concern for roll-out of LDCT screening is the risk associated with a false-positive result, 12, 13 for which the implications (e.g., follow-up testing with the potential for more invasive biopsies and additional radiation) need to be properly identified and discussed with the patient. The requirement for shared decision-making is meant to assure that the potential risks, benefits, limitations, and uncertainties associated with LDCT screening are conveyed to the patient and that the patient has an opportunity to ask questions before a LDCT is ordered. Effectiveness of these sessions may be limited, however, given concern among providers that a lack of patient knowledge about LDCT presents a major barrier to LDCT screening. 10 There is a clear need to address this knowledge gap as part of the larger effort to facilitate mutual respect and effective communication processes that are known to enhance the shared decision making process. 14 Our team assessed whether a population approach to increasing awareness of the new guidelines might be effective in addressing the expectedly slow uptake of the screening initiative.
To this end, we developed a community awareness campaign about the importance of lung cancer screening that would be especially sensitive to the unique cultural attitudes and perspectives in the high-need area of Eastern Kentucky. Our community-engaged approach utilized focus groups of local individuals who met criteria to be considered high-risk for lung cancer. Focus groups were gathered to elicit their opinions about lung cancer, lung cancer screening, and perceived salient and trusted messages about screening. Here we report on the effectiveness of the resulting campaign, known as the Terminate Lung Cancer (TLC) program, based on community awareness of screening and rates of LDCT orders across two targeted Eastern Kentucky regions. Prior research describes development of our campaign materials and highlights our community-engaged approach as informed by our focus group efforts. 9 We hypothesized that if our TLC program had met its goal of motivating patients to approach their health providers about their options for LDCT, there would be an increase in order rates for
LDCT as compared to a control region where the campaign had not been implemented.
Methods

Targeted population regions.
We targeted three Eastern Kentucky regions located in and around the counties with the residing cities of Morehead, Hazard, and Pikeville, KY ( Figure 1 ). Each of these areas is burdened with significant health disparities, and is characterized by significant behavioral, educational, and economic disparities (see Table 1 ).
Mixed methods approach.
A sequential mixed-methods approach was implemented with focus group sessions conducted in October 2014, followed by implementation of the community outreach intervention in two intervention regions (Morehead and Hazard regions). The Pikeville region did not receive the marketing intervention and served as a control region for assessment of LDCT rates. All study procedures were approved by the University of Kentucky Institutional Review Board. All sessions were recorded and transcribed for independent content analysis, with results described in a previous publication. 9 Among the findings from these deliberative sessions was a list of themes that were identified for their potential effectiveness; these included messages about survivorship, family, and prolonged life. There was strong consensus among participants of the importance of testimony, such as seeing a picture of someone who had survived lung cancer after screening. With regard to the various venues and channels that might be used to disseminate information about lung cancer screening, this largely older and rural audience showed heavy reliance on information gained from their health providers, as well as family and friends.
Recommendations also included: Flyers or information in doctor offices/waiting rooms and during annual exams; making LDCT screening information available in internet searches and in health websites; placing flyers in grocery stores and by direct mail; and traditional advertising using television, newspaper, and radio advertisements.
Development of lung cancer screening campaign: Campaign elements.
The media, venues, and methods of the campaign were informed by the outcomes of the focus group data described above. We developed messaging and images for postcard mailings and newspaper ads that included a TLC website address (See Figure 2) . The TLC campaign did not include any television advertisements due to cost limitations. As described in our previous publication 9 , two members from each focus group were asked to serve on an advisory board that participated in the development of the campaign elements, including final approval of all venues and materials used. Their function was to provide input and direction to ensure that perspectives of the targeted population, as derived from the focus groups in which they participated, were fully vetted and reflected in the messages and outcomes produced. The final materials (see Figure 2 ) were selected to portray the common message of hope and survival, as this was an overriding theme discussed during the focus groups.
Campaign dissemination (intervention).
With importance given to information provided by a family doctor or specialty provider, Along with the postcards, we enclosed information specific to providers on the LDCT guidelines, and a crosswalk comparison of the CMS coverage and the United States Preventive Services Task Force recommendations. We developed a website (www.terminatelungcancer.org) with links and resources for community members and providers, and sent a second letter to the same providers marketing the website. We held a physician roundtable event to provide an overview of our project and the LDCT screening guidelines in the Morehead region, which was attended by 26 physicians. A Hazard region roundtable was unfortunately canceled due to an insufficient number of registered participants.
For broader community coverage, we purchased ads using the same design as the postcards that ran every 2 weeks in 17 community newspapers (9 in the Morehead region and 8 in the Hazard region). For radio coverage, we ran ads on the local public radio station in the Morehead region twice daily for 6-months. Likewise in the Hazard region, we worked with 2 local radio stations to run our spot one or more times per day. The radio ads message is shown in In order to assess reach of the campaign and community access to our dissemination efforts, we analyzed results from a telephone survey that was administered by three CHWs from each region. Call lists were generated from Kentucky Homeplace using their established client files to include members meeting the screening criteria described above, excluding any individuals who had participated in any of the prior six focus groups sessions. In their telephone call, respondents were asked if they had seen or heard any advertising, or other exposure, concerning lung cancer screening. If a respondent answered yes, they were asked where the ad was seen and/or heard, and if the exposure influenced them toward any specific considerations or to take action toward screening or smoking cessation. To monitor for external marketing activity by regional systems, specifically by hospital centers that offer LDCT, our team called and sent emails attempting to reach each hospital's director of marketing, radiology or medical imaging center, and/or supervisor for oncology services. Feedback from this assessment was used to qualitatively interpret comparative analyses of campaign effectiveness.
Statistical approach.
Survey results were assessed using descriptive and bivariate analyses. Counts and frequencies were calculated and chi-square analysis was performed to assess for statistical differences between the three studied regions. Statistical significance was achieved based on a pvalue <0.05 using SPSS version 21.0 software.
LDCT-Statistical process control.
We used statistical process control with our primary process measure of LDCTs for each region (calculated as number of LDCTs performed per population 100,000) displayed on control (c-) charts. This methodology assesses whether a process is stable (with variation only coming from sources that would be usual or common to the process), and we used established rules for differentiating special versus common cause variation for each c-chart. [16] [17] [18] We plotted TLC campaign elements on the c-charts to assess for any temporal trends that may have arisen. Upper and lower control limits (UCL and LCL, respectively) were used to determine if special cause variation (points on the timeline that exceed estimates of expected variability) achieved statistical significance. UCL and LCL for c-control charts are based on count data that are assumed to follow a Poisson distribution and based on the central limit theorem. 19 Standard deviations are calculated as the square root of the mean central line defined as the sum of events (i.e., LDCTs)
divided by the number of subgroups (i.e., number of time points). The upper and lower control limits are then calculated as the mean central line +/-3 multiplied by the square root of the mean central line.
Results
Study population regions
While the Eastern Kentucky region is very homogenous, the region drastically differs in several measures when compared to non-Appalachia Kentucky and the rest of the US. Low education and income levels, as presented in Table 1 , are lower in the study regions when compared to Kentucky and the US. In addition, smoking rates are almost doubled when compared to the US and approximately 5% higher than the state average. Similar disproportionate patterns are observed for premature death and cancer death rates.
Exposure and Behaviors Survey results.
CHWs attempted to reach at least 50 screening-eligible individuals in each of the three regions. A total of 145 surveys were completed in all regions combined. Seventy-three (50.3%) answered "Yes" to the question of whether they had "seen or heard ads, messages, or postcards about lung cancer screening in doctor offices, local newspapers, or on the radio in the last 4-6 months." When the 73 individuals were asked if this exposure had led to any consideration and/or action, a total of 61 individuals (83.6%) reported a positive response for at least one consideration or action taken, with a total of 100 considerations or behaviors reported. Results of this survey, including reports of exposure to the different campaign elements (described next), are shown in Table 2 .
Comparison of individuals reporting that they had seen or heard about lung cancer screening in the last 4-6 months did not reveal any significant difference in overall exposure across the three regions (p=0.13). There were significant differences in the type of activity to which regions were exposed. Our two intervention regions both reported high rates of radio ad exposure compared to the Pikeville (Control) region (p=0.02). The Morehead region had the highest percentage reporting exposure to postcards in doctor offices and newspaper ads (p=0.01), with lower rates in the Hazard and Pikeville regions. A large percentage of respondents in the Pikeville (Control) region stated that they had seen television ads about lung cancer screening (not part of our campaign), which was significantly more than was found amongst those surveyed in the intervention regions (p<.001).
LDCT results.
As shown on the c-charts for each region, there was a significant uptake (exceeding the upper control limit) of LDCTs in the two intervention regions (Figure 3a) , while no statistical significance was achieved in the Control region (Figure 3b) . Moreover, the increasing trend in uptake of LDCTs was noted to occur after incremental elements of the TLC campaign were Translating recommendations and guidelines into practice is a lengthy process, taking an estimated 17 years to proceed from initial discovery to clinical implementation. 20 The U.S. health care system heavily relies on published reports and continuing education to disseminate new guidelines, with the expectation that implementation will occur shortly thereafter -a passive practice that has not proven effective. 21, 22 Our study assesses the impact of directly disseminating knowledge and information to communities in Eastern Kentucky. The messaging and awareness campaign sought to encourage high-risk individuals to speak with their health care provider about whether lung cancer screening was appropriate for them. Through our population-level comparative analyses, we demonstrated significant uptake of LDCTs in intervention regions compared to a control region. This study provides preliminary evidence that implementing population approaches may be a viable method to disseminate new guidelines. Our study adds to existing literature on best practices and effectiveness of educational outreach (e.g., Greenhalgh et al. 23 and the AHRQ 24 ) among strategies that facilitate the knowledge translation process; 25 and perhaps more importantly, addresses the recognized academic-community divide that often limits the reach and/or meaningfulness of the education provided to the community. 26 As noted in the findings from our survey of exposure and behavior, the lung cancer screening campaign inadvertently triggered thought processes concerning smoking cessation.
This was a welcome unintended consequence of the campaign, and indicates that the participating population was aware that smoking is the primary risk factor for lung cancer. The finding also adds to the growing evidence base that smoking cessation interventions can be successfully implemented in screening settings. 27, 28 Evidence that patients associate smoking behaviors and the need for screening is important, given that CMS lung cancer screening guidelines require counseling on the importance of smoking cessation as part of the national coverage requirement, in addition to the shared decision making activities described earlier.
Limitations.
The location of our study may limit the generalizability of the results to other regions in the United States. First, our demographic is predominantly white, with approximately 85% of Kentucky residents in 2015 classified as White alone, not Hispanic or Latino (compared to 61.6% of the US population). The white demographic is even more prevalent in our study regions of Clay (92.7%), Pike (97.1%) and Rowan (94.5%) counties. 29 Second, advertising efforts in this region were specifically targeted to the unique population of individuals that live in rural Appalachian regions. Persons in these areas may not be reflective of other populations in terms of educational or other socio-demographic characteristics (see again, Table 1 ) or in terms of their access to campaign features that may be effective in other areas. For example, while our focus groups did communicate interest in obtaining health information from the internet, we did not anticipate this would be a strong driver for our campaign given that state statistics show that 23% of rural (and only 1.5% of urban) Kentuckians were without any internet access at the time of this study. 30 Thus, while our TLC website may serve as a model for the type of messaging that may be effective within that community, web and social media marketing could be of greater utility within more "connected" population centers than was explored here.
Another challenge in examining the effects of our advertising campaign on LDCT uptake related to the diffusion effects of the intervention to other regions, and evidence that we obtained for competing marketing that cannot be controlled. Methodologically, it is impossible to establish causality using our design. It is always difficult to establish a true control community for purposes of comparison, because one cannot assume that the community involved will remain static or uninfluenced by other campaigns or factors occurring in the experimental communities. 31 Respondents to our campaign exposure assessment within our Pikeville (Control) region stated that they had exposure to television ads about lung cancer screening; and in our effort to contact marketing agents we received information from one hospital system in the region that it had undergone an extensive lung cancer screening campaign. Indeed, given the level of exposure to LDCT marketing in the region that served as our Control, the greater effectiveness on obtained LDCT orders in our intervention regions speaks to the success of our campaign. It should be noted that while we were unable to obtain information about the content of the external ads, recent research shows aggressive appeals can make smokers feel stigmatized and engender distrust. 32 We suggest that our campaign, by using images and captions that express hope and survivorship and encouraged consultation with a physician or other clinician, offered a positive emotional message that was more trusted and stimulated more desired activity.
Measuring campaign dissemination effectiveness based on rates of LDCT orders presented additional challenges since the outcome measure depended on operational readiness to facilitate the change. Uptake of LDCT screening guidelines is likely to be affected by a host of systematic and administrative hurdles that delay order rates, and thus our reported rates may not adequately reflect the rate of screening that could be expected in later campaigns. In fact, in the assessment of the marketing efforts outside of our campaign, several hospital administrators outside of our LDCT centers commented that they haven't gotten the reimbursement "figured out yet" to begin screening. Nonetheless, our three hospital system partners were performing LDCT screenings, but differed in their maturity in operating and sustaining a lung cancer screening program. Another limitation is that we did not capture LDCTs that may have resulted from our campaign that were performed outside of our three partnering hospital systems.
Conclusion
Lung cancer accounts for approximately 20% of the total cost of cancer care to Medicare, with aggregate costs of $4.2 billion spent over a five-year span of care ($1-2 billion more than the cost of colorectal or prostate cancer). 33 Alerting to the need for early detection, these costs are known to increase for patients with more advanced disease at the time of initial diagnosis.
Unfortunately, those costs are often incurred by those who can least afford it, since late-stage diagnosis has been associated with lower socioeconomic status. 34, 35 Our goal was to increase lung cancer screening rates by addressing the knowledge barrier about LDCT screening processes, benefits, and risks in a community population known for significant health disparities and health-risk behaviors. While we found increases in each of our target regions, further research is needed to ascertain the true impact of population-level interventions in the dissemination and implementation process of new evidence-based screening guidelines. 
